Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antitumor effects of interferon.

I Gresser1

  • 1Laboratory of Viral Oncology, Groupe de Laboratoires de L'Institut de Recherches Scientifiques sur le Cancer, Villejuif, France.

Acta Oncologica (Stockholm, Sweden)
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of Plasmodium yoelii blood-stage malaria by interferon alpha through the inhibition of the production of its target cell, the reticulocyte.

Blood·2001
Same author

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

Immunity·2001
Same author

William E. Stewart II.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2000
Same author

Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major.

European journal of immunology·2000
Same author

Three remarkable teachers.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2000
Same author

Murine interferon-alpha1 gene-transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to interferon-alpha/beta therapy.

Cancer gene therapy·1999

Interferon, a protein naturally produced by the body, demonstrates antitumor effects against various cancers. Research in mice suggests interferon therapy can inhibit tumor growth and metastasis, offering potential treatment strategies for human malignancies.

Area of Science:

  • Immunology
  • Oncology
  • Virology

Background:

  • Natural and recombinant interferons exhibit antitumor activity in certain malignancies.
  • Interferon's historical development as an anticancer agent is reviewed.
  • Previous studies explored interferon's efficacy in preclinical models.

Purpose of the Study:

  • To review the development of interferon as an antitumor agent.
  • To examine interferon's effects on primary tumors and metastases in experimental models.
  • To provide insights into optimal interferon administration regimens for human use.

Main Methods:

  • Review of historical data on interferon therapy.
  • Preclinical studies using mice with spontaneous, virus-induced, or transplantable tumors.

Related Experiment Videos

  • Analysis of interferon's impact on tumor growth and metastasis.

    • Main Results:

    • Interferon demonstrated antitumor activity in preclinical models.
    • Interferon inhibited the growth of primary tumors.
    • Interferon also suppressed the development of metastases.

    Conclusions:

    • Experimental findings suggest potential optimal interferon administration regimens for humans.
    • Interferon's antitumor mechanisms remain largely unknown.
    • Interferon may exert direct effects on tumor cells and the tumor-bearing host.